Date: 17/09/2021<BR> To, <BR> <BR> Sub.: Outcome of the Meeting of the Board of Directors of the Company held on 17-09-2021 for the appointment of Dr. Sheela Bhide (DIN 01843547) as an Independent Director of the Company.<BR> <BR> Ref.: SCRIP CODE: NSE: - AHLUCONT, BSE: - 532811 - ISIN Code: INE758C01029<BR> Dear Sir/Madam,<BR> <BR> In Compliance with the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, the Board of Directors of the Company in their meeting held on 17-09-2021 had considered and approved for the appointment of Dr. Sheela Bhide (DIN 01843547),as an additional Director in the category of Independent Director to hold office for a period of 1 (one) year w.e.f 17-09-2021, subject to the approval of shareholders in the General Meeting of the Company, pursuant to the recommendation by the Nomination and Remuneration Committee. <BR> <BR> <BR>
|